Unresectable Fibrolamellar Carcinoma (DBCOND0129156)

Identifiers

Synonyms

Not Available

Associated Data

Indicated Drugs and Targets

Not Available

Clinical Trials

Identifier	Title	Drug(s)	Purpose	Phase	Status
NCT04380545	Nivolumab, Fluorouracil, and Interferon Alpha 2B for the Treatment of Unresectable Fibrolamellar Cancer	Fluorouracil Nivolumab Novaferon	treatment	1 / 2	suspended